Insurance Coverage for Drug Rehab: What Health Plans Must Cover
Federal law has required most health insurance plans to cover substance use disorder treatment since 2008, yet patients are still routinely denied care, handed surprise bills, or steered away from the level of treatment a clinician recommended. Understanding where the law draws the line — and where insurers still have room to maneuver — is the difference between getting into treatment and getting stuck on the phone.
Definition and scope
The legal foundation for insurance coverage of drug rehabilitation sits in two overlapping federal statutes. The Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) prohibits large group health plans from imposing more restrictive financial requirements or treatment limitations on mental health and substance use disorder benefits than those applied to medical or surgical benefits. Then the Affordable Care Act of 2010 (ACA) went further, classifying substance use disorder treatment as one of ten essential health benefits that most individual and small-group marketplace plans must include.
The practical scope of these protections is wide but not universal. Grandfathered plans — those that existed before March 23, 2010, and have not made significant changes — may be exempt from some ACA requirements. Self-insured employer plans are subject to MHPAEA parity rules but are not always required to offer substance use disorder benefits in the first place, a distinction the U.S. Department of Labor has acknowledged creates coverage gaps for roughly 100 million workers covered under such arrangements.
What "coverage" actually means varies by plan. At minimum, covered services typically include medically supervised detoxification, inpatient rehabilitation, residential treatment, intensive outpatient programs (IOP), standard outpatient counseling, and medication-assisted treatment (MAT) with FDA-approved medications such as buprenorphine, methadone, and naltrexone.
How it works
When a person seeks treatment through the rehab process, the insurance machinery follows a rough sequence:
- Verification of benefits — The facility or individual contacts the insurer to confirm active coverage, applicable deductibles, copay or coinsurance rates, and whether an in-network provider must be used.
- Prior authorization — Most plans require advance approval before covering residential or inpatient care. The insurer reviews clinical documentation to determine whether the requested level of care is "medically necessary."
- Level-of-care determination — Insurers typically apply proprietary criteria or reference the American Society of Addiction Medicine (ASAM) Patient Placement Criteria to decide whether inpatient, residential, or outpatient care is appropriate.
- Concurrent review — For inpatient stays, insurers conduct periodic reviews — sometimes every 3 to 7 days — to determine whether continued stay remains medically necessary.
- Appeals — If coverage is denied, patients and providers have the right to internal appeals and, in most states, external independent review.
The parity requirement is the critical lever here. Under MHPAEA, if a plan covers unlimited inpatient days for a cardiac event, it cannot impose a hard cap of 30 days for residential addiction treatment. The Department of Labor's 2023 final rule on MHPAEA (Federal Register, Vol. 88) strengthened requirements for plans to conduct and document comparative analyses demonstrating parity in nonquantitative treatment limitations (NQTLs) — the more subtle restrictions like prior authorization thresholds and reimbursement rate structures.
Common scenarios
Three situations account for the vast majority of coverage disputes people encounter when seeking help for drug rehab:
Out-of-network residential treatment. Many residential rehab facilities do not participate in any insurance network, particularly high-acuity or specialty programs. In these cases, coverage depends on whether the plan offers out-of-network benefits at all and at what reimbursement rate — often 50–60% of the plan's "allowed amount" after a separate out-of-network deductible is met. The gap between billed charges and allowed amounts can produce five-figure out-of-pocket costs even when insurance pays.
Medical necessity denials for higher levels of care. A clinician recommends residential treatment; the insurer approves intensive outpatient. This is the most common form of coverage conflict and the most directly addressed by parity law. Denials based on internal criteria that are more restrictive than those applied to analogous medical conditions are legally suspect under MHPAEA.
Medication-assisted treatment coverage gaps. Despite federal guidance, some plans still impose step-therapy requirements — requiring a patient to fail a non-medication approach before approving MAT — or impose quantity limits on buprenorphine prescriptions that have no equivalent restriction on other chronic disease medications. The Substance Abuse and Mental Health Services Administration (SAMHSA) identifies MAT as the gold standard for opioid use disorder, which strengthens the clinical argument in appeals.
Decision boundaries
Insurance coverage for rehab is not a binary yes-or-no question — it operates across a spectrum defined by plan type, network status, level of care, and state law. States can impose parity requirements stricter than federal law; California, New York, and Illinois, among others, have enacted additional mandates that expand coverage obligations for plans regulated at the state level.
The full dimensions of what rehab programs offer matter here because coverage decisions track clinical categories closely. Insurers distinguish between acute detoxification (usually 5–10 days), short-term residential (28–30 days), long-term residential (60–90+ days), partial hospitalization, and standard outpatient — each carrying different prior authorization hurdles and reimbursement structures.
Where coverage ends and patient cost begins also depends on benefit design: annual deductibles ranging from $500 to $8,700 (the 2024 ACA out-of-pocket maximum for individual plans is $9,450, per HealthCare.gov), coinsurance percentages, and any remaining lifetime or annual limits on behavioral health visits that a plan may attempt to apply — attempts that, if applied more harshly than to medical benefits, violate MHPAEA. For a broader orientation to the rehab landscape before navigating coverage questions, the drug rehab frequently asked questions page addresses common terminology and process questions.